Table 1.

Correlation between CBX8 expression and clinical pathological characteristics of HCC patients

Variables	Total	CBX8 staining		p value*
		High	Low
Gender
Male	66	36	30	0.417
Female	17	7	10
Age (years)
≥50	67	33	34	0.411
<50	16	10	6
HBsAg
Positive	60	29	31	0.337
Negative	23	14	9
Liver cirrhosis
Yes	55	25	30	0.163
No	28	18	10
AFP (ng/ml)
≥20	50	27	23	0.659
<20	33	16	17
γ-GT (U/L)
≥50	35	22	13	0.120
<50	48	21	27
ALT (U/L)
≥40	42	24	18	0.383
<40	41	19	22
AST (U/L)
≥40	38	20	18	1.000
<40	45	23	22
Tumor diameter (cm)
≥5	39	29	10	<0.001
<5	44	14	30
Tumor differentiation
I + II	51	18	33	<0.001
III	32	25	7
Tumor stage
I + II	43	16	27	0.008
III + IV	40	27	13
TNM stage
T1 + T2	47	18	29	0.008
T3 + T4	36	25	11
Metastasis
Yes	41	26	15	0.049
No	42	17	25

CBX8 Chromobox homolog 8, HCC hepatocellular carcinoma, HBsAg hepatitis B surface antigen, AFP α-fetoprotein, γ-GT γ-glutamyl transpeptidase, mRNA messenger RNA, AST aspartate transaminase, ALT alanine aminotransferase,TNM tumor node metastasis

*p value is based on the χ² test